Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

SSUPERNUS PHARMACEUTICALS, INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
S

SUPERNUS PHARMACEUTICALS, INC.

$43.75Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $219.06M. Net result −$58.37M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $219.06M. Running result $219.06M. APOKYN: $6.32M. Collaboration Revenue: $35.35M. GOCOVRI: $37.53M. Manufactured Product Other: $1.88M. ONAPGO: $13.55M. Oxtellar XR: $8.78M. Qelbree: $89.24M. Royalty License And Other Revenue: $18M. Trokendi Xr: $8.41M.
  • Cost of revenue: −$33.67M. Running result $185.39M.
  • Gross profit: $185.39M. Running result $185.39M.
  • Research and development: −$29.46M. Running result $155.93M.
  • Selling, general and administrative: −$133.64M. Running result $22.29M.
  • Amortization of intangible assets: −$25.33M. Running result −$3.04M.
  • Intangible asset impairment charges: −$54.92M. Running result −$57.96M.
  • Contingent consideration loss: $0. Running result −$57.96M.
  • Operating income: −$57.96M. Running result −$57.96M.
  • Other income: $315K. Running result −$57.65M.
  • Pre-tax loss: −$57.65M. Running result −$57.65M.
  • Income tax expense: −$723K. Running result −$58.37M.
  • Net loss: −$58.37M. Running result −$58.37M.